| 763778 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
491 BASECAMP-1: an observational study to identify relapsed solid tumor patients with human leukocyte antigen (HLA) loss of heterozygosity (LOH) and leukapheresis for future CAR T-cell therapy |
2021-11-01 |
10.1136/jitc-2021-sitc2021.491 |
Molina Julian, Go William, Kopetz Scott, Simeone Diane, Patel Sandip, Lin Yi, Liechty Kirstin, Fan-Port Michelle, Perera Jason, Mardiros Armen, Beutner Karl, Lozac’hmeur Ariane, Ng Eric, Maloney David, Randolph Hecht J |
| 763777 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
382 The synthetic long peptide cancer vaccine UV1 in combination with ipilimumab induces a CD4+ Th1 anti-hTERT immune response and an inflammatory tumor microenvironment in patients with melanoma |
2021-11-01 |
10.1136/jitc-2021-sitc2021.382 |
Ellingsen Espen, Kerzeli Iliana, Anzar Irantzu, Mensali Nadia, Clancy Trevor, Mangsbo Sara, Aamdal Steinar, Aamdal Elin, Guren Tormod, Inderberg-Suso Else-Marit, Hovig Eivind, Gaudernack Gustav |
| 763776 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
387 The utility of AI-powered spatial classification of intratumoral CD8+ immune-cell distribution in predicting overall survival in patients with melanoma as part of the checkMate 067 clinical trial |
2021-11-01 |
10.1136/jitc-2021-sitc2021.387 |
Lee George, Desai Keyur, Tang Hao, Cohen Daniel, Ely Scott, Wojcik John, Trillo-Tinoco Jimena, Chen Benjamin, Gupta Akshita, Tenney Daniel, Baxi Vipul, Edwards Robin, Wind-Rotolo Megan |
| 763775 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
546 Results from Phase Ib study of tebentafusp (tebe) in combination with durvalumab (durva) and/or tremelimumab (treme) in metastatic cutaneous melanoma (mCM) |
2021-11-01 |
10.1136/jitc-2021-sitc2021.546 |
Hamid Omid, Hassel Jessica, Shoushtari Alexander, Meier Friedegund, Bauer Todd, Salama April, Kirkwood John, Ascierto Paolo, Lorigan Paul, Mauch Cornelia, Orloff Marlana, Evans Jeff, Edukulla Ramakrishna, Holland Chris, Abdullah Shaad, Mundy Renee, Middleton Mark |
| 763774 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
498 Evorpacept (ALX148), a CD47 myeloid checkpoint inhibitor, in patients with head and neck squamous cell carcinoma (HNSCC) and with gastric/gastroesophageal cancer (GC); ASPEN-01 |
2021-11-01 |
10.1136/jitc-2021-sitc2021.498 |
Lee Keun-Wook, Chung Hyun, Kim Tae Min, Lakhani Nehal, Messersmith Wells, Santana-Davila Rafael, Kim Won Seog, LoRusso Patricia, Bang Yung-Jue, Chow Laura, Fanning Philip, Squifflet Pierre, Jin Feng, Forgie Alison, Wan Hong, Pons Jaume, Randolph Sophia, Gainor Justin |
| 763773 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
460 Spatial distribution of infiltrating T lymphocytes with Immunoscore® CR T cells exhaustion test helps stratification of NSCLC patients treated with PD1/PDL1 inhibitors in the PIONeeR project |
2021-11-01 |
10.1136/jitc-2021-sitc2021.460 |
Leca Vanina, Kassambara Alboukadel, Ghezali Lamia, Outters Pernelle, Cotteaux-Lautard Christelle, Arnoux Fanny, Sbarrato Thomas, Monville Florence, Monville Florence, Ray Maryannick Le, Roumieux Marie, Garcia Stephane, Malkoun Richard, Resseguier Noémie, Boyer Arnaud, Lebas Louisiane, Pegliasco Hervé, Barré Patricia, Audigier-valette Clarisse, Zahi Sarah, Odier Luc, Hominal Stéphane, Perol Maurice, Mazieres Julien, Greillier Laurent, Barlesi Fabrice, Fieschi-Meric Jacques |
| 763772 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
384 An investigation into the role of CD4+ tumor-infiltrating lymphocytes (TIL) in metastatic melanoma patients with a complete response to adoptive cell therapy |
2021-11-01 |
10.1136/jitc-2021-sitc2021.384 |
Hall MacLean, Branthoover Holly, Innamarato Patrick, Hall Amy, Alfaro Alex, Richards Allison, Rich Jeani, Hensel Jonathan, Bender Jim, Ceccarelli Jake, Langer TJ, Beatty Matthew, Mullinax John, Teer Jamie, Sarnaik Amod, Pilon-Thomas Shari |
| 763771 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
174 Combined IL-2, agonistic CD3 and 4–1BB stimulation preserve clonotype hierarchy in propagated non-small cell lung cancer tumor-infiltrating lymphocytes |
2021-11-01 |
10.1136/jitc-2021-sitc2021.174 |
Frank Meredith, Shah Parin, Forget Marie Andree, Federico Lorenzo, Jiang Peixin, Khairullah Roohussaba, Wistuba Ignacio, Chow Chi-Wan, Long Yan, Fujimoto Junya, Lin Shiaw-Yih, Maitra Anirban, Negrao Marcelo, Mitchell Kyle, Weissferdt Annika, Vaporciyan Ara, Cascone Tina, Roth Jack, Zhang Jianjun, Sepesi Boris, Gibbons Don, Heymach John, Haymaker Cara, McGrail Daniel, Bernatchez Chantale, Reuben Alexandre |
| 763770 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
626 Dissecting the spatial heterogeneity of SARS-CoV-2-infected tumour microenvironment reveals a lymphocyte-dominant immune response in a HBV-associated HCC patient with COVID-19 history |
2021-11-01 |
10.1136/jitc-2021-sitc2021.626 |
Tan Benedict, Yang Yi, Lawrence Cheung Chun Chau, Goh Denise, Lau Mai Chan, Lim Xinru, Lim Jeffrey, Nadia Lee Li Wen Justina, Tien Tracy, Kalimuddin Shirin, David Tai Wai Meng, Low Jenny, Young Ng Cedric Chuan, Leow Wei Qiang, Tan Thuan Tong, Lim Tony, Liu Jin, Yeong Joe |
| 763769 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
VCN-01 disrupts pancreatic cancer stroma and exerts antitumor effects |
2021-11-01 |
10.1136/jitc-2021-003254 |
Bazan-Peregrino Miriam, Garcia-Carbonero Rocio, Laquente Berta, Álvarez Rafael, Mato-Berciano Ana, Gimenez-Alejandre Marta, Morgado Sara, Rodríguez-García Alba, Maliandi Maria V, Riesco M Carmen, Moreno Rafael, Ginestà Mireia M, Perez-Carreras Mercedes, Gornals Joan B, Prados Susana, Perea Sofía, Capella Gabriel, Alemany Ramon, Salazar Ramon, Blasi Emma, Blasco Carmen, Cascallo Manel, Hidalgo Manuel |
